Healthy volunteers test new inhaled drug for lung condition
NCT ID NCT05567367
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 25 times
Summary
This early-stage study tested the safety of an inhaled drug called RT234 in 31 healthy adults aged 18 to 45. Researchers measured side effects and how the drug moves through the body. The goal was to gather basic safety information before testing it in people with pulmonary arterial hypertension.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network, Burnet Institute
Prahran, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.